The heart failure interactome

心力衰竭相互作用组

基本信息

  • 批准号:
    9816197
  • 负责人:
  • 金额:
    $ 66.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Heart disease is the leading cause of death of both men and women in the US with more than 900,000 deaths each year. Heart failure is a complex disorder, characterized by impaired myocardium contractile ability that delivers inadequate amounts of blood to meet demands of all organs. In the heart, mitochondrial oxidative phosphorylation is the source of 90% of the myocardial energy requirement. In the progression of heart failure, mitochondrial dysfunction has become widely accepted as a key part of maladaptive remodeling. Changes in mitochondrial function during heart failure have remained difficult to define on a molecular level and include altered protein levels, conformations and protein-protein interactions. Elevation in NADH/NAD+ ratio caused by cardiac overload was previously found to regulate mitochondrial protein lysine acetylation and result in changes in protein interactions involving a primary regulator of mitochondrial permeability transition pore sensitization to stress. Large-scale quantitative interactome analysis could reveal what protein conformational and interaction changes are involved in heart failure and provide new targets that can be tested for alleviation in cardiac hypertrophy and dysfunction in heart failure models. This project will develop isobaric quantitative Protein Interaction Reporter (iqPIR) technologies and apply them to study mitochondrial protein interactions and conformational regulation in heart failure. In addition, parallel reaction monitoring assays will be developed for iqPIR cross-linked peptides to yield a generally useful method for quantification of protein interactions and conformational features in any future mitochondrial study.
心脏病是美国男性和女性死亡的主要原因, 每年有90万人死亡。心力衰竭是一种复杂的疾病,其特征在于受损的 心肌收缩能力,提供不足量的血液,以满足所有的需求 机关在心脏中,线粒体氧化磷酸化是90%的 心肌能量需求在心力衰竭的发展过程中,线粒体功能障碍 已被广泛认为是适应不良性重塑的关键部分。变化 心力衰竭期间线粒体功能仍然难以在分子水平上定义 并且包括改变的蛋白质水平、构象和蛋白质-蛋白质相互作用。升高 先前发现心脏超负荷引起的NADH/NAD+比率调节线粒体 蛋白质赖氨酸乙酰化,并导致蛋白质相互作用的变化, 线粒体通透性转换孔对应激敏感的调节剂。大规模 定量相互作用组分析可以揭示蛋白质构象和相互作用 这些变化与心力衰竭有关,并提供了新的靶点,可用于缓解心力衰竭。 心力衰竭模型中的心脏肥大和功能障碍。该项目将开发等压 定量蛋白质相互作用报告(iqPIR)技术,并将其应用于研究 心力衰竭中线粒体蛋白质相互作用和构象调节。此外,本发明还提供了一种方法, 将开发用于iqPIR交联肽的平行反应监测测定,以产生 通常用于定量蛋白质相互作用和构象特征的方法, 任何线粒体研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Edward Bruce其他文献

James Edward Bruce的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Edward Bruce', 18)}}的其他基金

Aging Mitochondrial Interactome
衰老线粒体相互作用组
  • 批准号:
    10658412
  • 财政年份:
    2023
  • 资助金额:
    $ 66.62万
  • 项目类别:
Aging Mitochondrial Interactome
衰老线粒体相互作用组
  • 批准号:
    10688325
  • 财政年份:
    2022
  • 资助金额:
    $ 66.62万
  • 项目类别:
Dynamics of the cellular interactome
细胞相互作用组的动力学
  • 批准号:
    10398009
  • 财政年份:
    2020
  • 资助金额:
    $ 66.62万
  • 项目类别:
Dynamics of the cellular interactome
细胞相互作用组的动力学
  • 批准号:
    10613517
  • 财政年份:
    2020
  • 资助金额:
    $ 66.62万
  • 项目类别:
The heart failure interactome
心力衰竭相互作用组
  • 批准号:
    10447592
  • 财政年份:
    2019
  • 资助金额:
    $ 66.62万
  • 项目类别:
The heart failure interactome
心力衰竭相互作用组
  • 批准号:
    10218262
  • 财政年份:
    2019
  • 资助金额:
    $ 66.62万
  • 项目类别:
Investigating treatment resistance mechanisms in chronic bacterial infections
研究慢性细菌感染的治疗耐药机制
  • 批准号:
    8341304
  • 财政年份:
    2012
  • 资助金额:
    $ 66.62万
  • 项目类别:
Investigating treatment resistance mechanisms in chronic bacterial infections
研究慢性细菌感染的治疗耐药机制
  • 批准号:
    8470546
  • 财政年份:
    2012
  • 资助金额:
    $ 66.62万
  • 项目类别:
Investigating treatment resistance mechanisms in chronic bacterial infections
研究慢性细菌感染的治疗耐药机制
  • 批准号:
    9081460
  • 财政年份:
    2012
  • 资助金额:
    $ 66.62万
  • 项目类别:
Investigating treatment resistance mechanisms in chronic bacterial infections
研究慢性细菌感染的治疗耐药机制
  • 批准号:
    8685119
  • 财政年份:
    2012
  • 资助金额:
    $ 66.62万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了